nodes	percent_of_prediction	percent_of_DWPC	metapath
Hydrocodone—Naloxone—TLR4—esophageal cancer	0.0351	0.585	CrCbGaD
Hydrocodone—Night sweats—Capecitabine—esophageal cancer	0.0125	0.0315	CcSEcCtD
Hydrocodone—Hearing impaired—Cisplatin—esophageal cancer	0.00963	0.0242	CcSEcCtD
Hydrocodone—Body temperature increased—Carboplatin—esophageal cancer	0.00881	0.0222	CcSEcCtD
Hydrocodone—Hydromorphone—PTGS1—esophageal cancer	0.00854	0.142	CrCbGaD
Hydrocodone—Contusion—Capecitabine—esophageal cancer	0.00774	0.0195	CcSEcCtD
Hydrocodone—Gastrooesophageal reflux disease—Capecitabine—esophageal cancer	0.00748	0.0188	CcSEcCtD
Hydrocodone—Deafness—Cisplatin—esophageal cancer	0.00744	0.0187	CcSEcCtD
Hydrocodone—Hearing impaired—Capecitabine—esophageal cancer	0.0071	0.0178	CcSEcCtD
Hydrocodone—Neck pain—Capecitabine—esophageal cancer	0.00684	0.0172	CcSEcCtD
Hydrocodone—Dehydration—Cisplatin—esophageal cancer	0.00619	0.0156	CcSEcCtD
Hydrocodone—Hypokalaemia—Cisplatin—esophageal cancer	0.00606	0.0152	CcSEcCtD
Hydrocodone—Naltrexone—ABCB1—esophageal cancer	0.00573	0.0955	CrCbGaD
Hydrocodone—Abdominal discomfort—Cisplatin—esophageal cancer	0.00551	0.0139	CcSEcCtD
Hydrocodone—Deafness—Capecitabine—esophageal cancer	0.00548	0.0138	CcSEcCtD
Hydrocodone—Hot flush—Capecitabine—esophageal cancer	0.00524	0.0132	CcSEcCtD
Hydrocodone—Menopausal symptoms—Capecitabine—esophageal cancer	0.0052	0.0131	CcSEcCtD
Hydrocodone—Lethargy—Capecitabine—esophageal cancer	0.005	0.0126	CcSEcCtD
Hydrocodone—Osteoarthritis—Capecitabine—esophageal cancer	0.0049	0.0123	CcSEcCtD
Hydrocodone—Pain in extremity—Capecitabine—esophageal cancer	0.0049	0.0123	CcSEcCtD
Hydrocodone—Migraine—Capecitabine—esophageal cancer	0.00483	0.0121	CcSEcCtD
Hydrocodone—Urinary retention—Capecitabine—esophageal cancer	0.00466	0.0117	CcSEcCtD
Hydrocodone—Mood swings—Capecitabine—esophageal cancer	0.00465	0.0117	CcSEcCtD
Hydrocodone—Dehydration—Capecitabine—esophageal cancer	0.00456	0.0115	CcSEcCtD
Hydrocodone—Connective tissue disorder—Cisplatin—esophageal cancer	0.00452	0.0114	CcSEcCtD
Hydrocodone—Hypokalaemia—Capecitabine—esophageal cancer	0.00446	0.0112	CcSEcCtD
Hydrocodone—Naloxone—ABCB1—esophageal cancer	0.00418	0.0697	CrCbGaD
Hydrocodone—Mediastinal disorder—Cisplatin—esophageal cancer	0.00415	0.0104	CcSEcCtD
Hydrocodone—Abdominal discomfort—Capecitabine—esophageal cancer	0.00406	0.0102	CcSEcCtD
Hydrocodone—Malnutrition—Cisplatin—esophageal cancer	0.00401	0.0101	CcSEcCtD
Hydrocodone—Upper respiratory tract infection—Capecitabine—esophageal cancer	0.00394	0.0099	CcSEcCtD
Hydrocodone—Muscle spasms—Cisplatin—esophageal cancer	0.00385	0.00968	CcSEcCtD
Hydrocodone—Tremor—Cisplatin—esophageal cancer	0.00375	0.00944	CcSEcCtD
Hydrocodone—Lethargy—Methotrexate—esophageal cancer	0.00373	0.00937	CcSEcCtD
Hydrocodone—Urinary tract infection—Capecitabine—esophageal cancer	0.00367	0.00924	CcSEcCtD
Hydrocodone—Osteoarthritis—Methotrexate—esophageal cancer	0.00365	0.00918	CcSEcCtD
Hydrocodone—Morphine—ABCB1—esophageal cancer	0.00353	0.0588	CrCbGaD
Hydrocodone—Agranulocytosis—Capecitabine—esophageal cancer	0.00353	0.00887	CcSEcCtD
Hydrocodone—Convulsion—Cisplatin—esophageal cancer	0.00347	0.00873	CcSEcCtD
Hydrocodone—Mood swings—Methotrexate—esophageal cancer	0.00346	0.0087	CcSEcCtD
Hydrocodone—Myalgia—Cisplatin—esophageal cancer	0.00341	0.00858	CcSEcCtD
Hydrocodone—Anxiety—Cisplatin—esophageal cancer	0.0034	0.00855	CcSEcCtD
Hydrocodone—Unspecified disorder of skin and subcutaneous tissue—Cisplatin—esophageal cancer	0.00339	0.00852	CcSEcCtD
Hydrocodone—Oedema peripheral—Capecitabine—esophageal cancer	0.00334	0.0084	CcSEcCtD
Hydrocodone—Connective tissue disorder—Capecitabine—esophageal cancer	0.00333	0.00838	CcSEcCtD
Hydrocodone—Nervous system disorder—Cisplatin—esophageal cancer	0.00321	0.00806	CcSEcCtD
Hydrocodone—Thrombocytopenia—Cisplatin—esophageal cancer	0.0032	0.00805	CcSEcCtD
Hydrocodone—Skin disorder—Cisplatin—esophageal cancer	0.00318	0.00799	CcSEcCtD
Hydrocodone—Hyperhidrosis—Cisplatin—esophageal cancer	0.00316	0.00795	CcSEcCtD
Hydrocodone—Angiopathy—Capecitabine—esophageal cancer	0.00308	0.00774	CcSEcCtD
Hydrocodone—Mediastinal disorder—Capecitabine—esophageal cancer	0.00306	0.00769	CcSEcCtD
Hydrocodone—Hypotension—Cisplatin—esophageal cancer	0.00306	0.00768	CcSEcCtD
Hydrocodone—Abdominal discomfort—Methotrexate—esophageal cancer	0.00303	0.00761	CcSEcCtD
Hydrocodone—Musculoskeletal discomfort—Cisplatin—esophageal cancer	0.00298	0.00749	CcSEcCtD
Hydrocodone—Mental disorder—Capecitabine—esophageal cancer	0.00297	0.00747	CcSEcCtD
Hydrocodone—Dextromethorphan—ABCB1—esophageal cancer	0.00296	0.0494	CrCbGaD
Hydrocodone—Malnutrition—Capecitabine—esophageal cancer	0.00295	0.00743	CcSEcCtD
Hydrocodone—Paraesthesia—Cisplatin—esophageal cancer	0.00294	0.00738	CcSEcCtD
Hydrocodone—Upper respiratory tract infection—Methotrexate—esophageal cancer	0.00293	0.00737	CcSEcCtD
Hydrocodone—Dyspnoea—Cisplatin—esophageal cancer	0.00292	0.00733	CcSEcCtD
Hydrocodone—Back pain—Capecitabine—esophageal cancer	0.00286	0.00718	CcSEcCtD
Hydrocodone—Muscle spasms—Capecitabine—esophageal cancer	0.00284	0.00714	CcSEcCtD
Hydrocodone—Gastrointestinal disorder—Cisplatin—esophageal cancer	0.00282	0.0071	CcSEcCtD
Hydrocodone—Drowsiness—Methotrexate—esophageal cancer	0.00281	0.00707	CcSEcCtD
Hydrocodone—Tremor—Capecitabine—esophageal cancer	0.00277	0.00696	CcSEcCtD
Hydrocodone—Agranulocytosis—Methotrexate—esophageal cancer	0.00263	0.0066	CcSEcCtD
Hydrocodone—Body temperature increased—Cisplatin—esophageal cancer	0.00259	0.0065	CcSEcCtD
Hydrocodone—Cough—Capecitabine—esophageal cancer	0.00258	0.00648	CcSEcCtD
Hydrocodone—Myalgia—Capecitabine—esophageal cancer	0.00251	0.00632	CcSEcCtD
Hydrocodone—Arthralgia—Capecitabine—esophageal cancer	0.00251	0.00632	CcSEcCtD
Hydrocodone—Anxiety—Capecitabine—esophageal cancer	0.00251	0.0063	CcSEcCtD
Hydrocodone—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—esophageal cancer	0.0025	0.00628	CcSEcCtD
Hydrocodone—Dry mouth—Capecitabine—esophageal cancer	0.00246	0.00618	CcSEcCtD
Hydrocodone—Hypersensitivity—Cisplatin—esophageal cancer	0.00241	0.00606	CcSEcCtD
Hydrocodone—Nervous system disorder—Capecitabine—esophageal cancer	0.00236	0.00594	CcSEcCtD
Hydrocodone—Thrombocytopenia—Capecitabine—esophageal cancer	0.00236	0.00593	CcSEcCtD
Hydrocodone—Asthenia—Cisplatin—esophageal cancer	0.00235	0.0059	CcSEcCtD
Hydrocodone—Skin disorder—Capecitabine—esophageal cancer	0.00234	0.00589	CcSEcCtD
Hydrocodone—Hyperhidrosis—Capecitabine—esophageal cancer	0.00233	0.00586	CcSEcCtD
Hydrocodone—Angiopathy—Methotrexate—esophageal cancer	0.00229	0.00576	CcSEcCtD
Hydrocodone—Mediastinal disorder—Methotrexate—esophageal cancer	0.00228	0.00572	CcSEcCtD
Hydrocodone—Hypotension—Capecitabine—esophageal cancer	0.00225	0.00566	CcSEcCtD
Hydrocodone—Mental disorder—Methotrexate—esophageal cancer	0.00221	0.00556	CcSEcCtD
Hydrocodone—Malnutrition—Methotrexate—esophageal cancer	0.0022	0.00553	CcSEcCtD
Hydrocodone—Musculoskeletal discomfort—Capecitabine—esophageal cancer	0.0022	0.00552	CcSEcCtD
Hydrocodone—Insomnia—Capecitabine—esophageal cancer	0.00218	0.00548	CcSEcCtD
Hydrocodone—Paraesthesia—Capecitabine—esophageal cancer	0.00216	0.00544	CcSEcCtD
Hydrocodone—Dyspnoea—Capecitabine—esophageal cancer	0.00215	0.0054	CcSEcCtD
Hydrocodone—Back pain—Methotrexate—esophageal cancer	0.00213	0.00535	CcSEcCtD
Hydrocodone—Gastrointestinal disorder—Capecitabine—esophageal cancer	0.00208	0.00523	CcSEcCtD
Hydrocodone—Vomiting—Cisplatin—esophageal cancer	0.00208	0.00523	CcSEcCtD
Hydrocodone—Fatigue—Capecitabine—esophageal cancer	0.00208	0.00522	CcSEcCtD
Hydrocodone—Rash—Cisplatin—esophageal cancer	0.00206	0.00518	CcSEcCtD
Hydrocodone—Constipation—Capecitabine—esophageal cancer	0.00206	0.00518	CcSEcCtD
Hydrocodone—Dermatitis—Cisplatin—esophageal cancer	0.00206	0.00518	CcSEcCtD
Hydrocodone—Gastrointestinal pain—Capecitabine—esophageal cancer	0.00197	0.00496	CcSEcCtD
Hydrocodone—Nausea—Cisplatin—esophageal cancer	0.00194	0.00488	CcSEcCtD
Hydrocodone—Cough—Methotrexate—esophageal cancer	0.00192	0.00482	CcSEcCtD
Hydrocodone—Body temperature increased—Capecitabine—esophageal cancer	0.00191	0.00479	CcSEcCtD
Hydrocodone—Abdominal pain—Capecitabine—esophageal cancer	0.00191	0.00479	CcSEcCtD
Hydrocodone—Convulsion—Methotrexate—esophageal cancer	0.00191	0.00479	CcSEcCtD
Hydrocodone—Myalgia—Methotrexate—esophageal cancer	0.00187	0.00471	CcSEcCtD
Hydrocodone—Arthralgia—Methotrexate—esophageal cancer	0.00187	0.00471	CcSEcCtD
Hydrocodone—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—esophageal cancer	0.00186	0.00467	CcSEcCtD
Hydrocodone—Hypersensitivity—Capecitabine—esophageal cancer	0.00178	0.00446	CcSEcCtD
Hydrocodone—Nervous system disorder—Methotrexate—esophageal cancer	0.00176	0.00442	CcSEcCtD
Hydrocodone—Thrombocytopenia—Methotrexate—esophageal cancer	0.00176	0.00442	CcSEcCtD
Hydrocodone—Skin disorder—Methotrexate—esophageal cancer	0.00174	0.00438	CcSEcCtD
Hydrocodone—Hyperhidrosis—Methotrexate—esophageal cancer	0.00173	0.00436	CcSEcCtD
Hydrocodone—Asthenia—Capecitabine—esophageal cancer	0.00173	0.00435	CcSEcCtD
Hydrocodone—Pruritus—Capecitabine—esophageal cancer	0.00171	0.00429	CcSEcCtD
Hydrocodone—Hypotension—Methotrexate—esophageal cancer	0.00168	0.00422	CcSEcCtD
Hydrocodone—Musculoskeletal discomfort—Methotrexate—esophageal cancer	0.00163	0.00411	CcSEcCtD
Hydrocodone—Insomnia—Methotrexate—esophageal cancer	0.00162	0.00408	CcSEcCtD
Hydrocodone—Paraesthesia—Methotrexate—esophageal cancer	0.00161	0.00405	CcSEcCtD
Hydrocodone—Dyspnoea—Methotrexate—esophageal cancer	0.0016	0.00402	CcSEcCtD
Hydrocodone—Somnolence—Methotrexate—esophageal cancer	0.0016	0.00401	CcSEcCtD
Hydrocodone—Dizziness—Capecitabine—esophageal cancer	0.00159	0.00401	CcSEcCtD
Hydrocodone—Gastrointestinal disorder—Methotrexate—esophageal cancer	0.00155	0.00389	CcSEcCtD
Hydrocodone—Fatigue—Methotrexate—esophageal cancer	0.00155	0.00389	CcSEcCtD
Hydrocodone—Vomiting—Capecitabine—esophageal cancer	0.00153	0.00385	CcSEcCtD
Hydrocodone—Rash—Capecitabine—esophageal cancer	0.00152	0.00382	CcSEcCtD
Hydrocodone—Dermatitis—Capecitabine—esophageal cancer	0.00152	0.00382	CcSEcCtD
Hydrocodone—Headache—Capecitabine—esophageal cancer	0.00151	0.0038	CcSEcCtD
Hydrocodone—Gastrointestinal pain—Methotrexate—esophageal cancer	0.00147	0.00369	CcSEcCtD
Hydrocodone—Nausea—Capecitabine—esophageal cancer	0.00143	0.0036	CcSEcCtD
Hydrocodone—Abdominal pain—Methotrexate—esophageal cancer	0.00142	0.00357	CcSEcCtD
Hydrocodone—Body temperature increased—Methotrexate—esophageal cancer	0.00142	0.00357	CcSEcCtD
Hydrocodone—Hypersensitivity—Methotrexate—esophageal cancer	0.00132	0.00332	CcSEcCtD
Hydrocodone—Asthenia—Methotrexate—esophageal cancer	0.00129	0.00324	CcSEcCtD
Hydrocodone—Pruritus—Methotrexate—esophageal cancer	0.00127	0.00319	CcSEcCtD
Hydrocodone—Dizziness—Methotrexate—esophageal cancer	0.00119	0.00298	CcSEcCtD
Hydrocodone—Vomiting—Methotrexate—esophageal cancer	0.00114	0.00287	CcSEcCtD
Hydrocodone—Rash—Methotrexate—esophageal cancer	0.00113	0.00284	CcSEcCtD
Hydrocodone—Dermatitis—Methotrexate—esophageal cancer	0.00113	0.00284	CcSEcCtD
Hydrocodone—Headache—Methotrexate—esophageal cancer	0.00112	0.00283	CcSEcCtD
Hydrocodone—Nausea—Methotrexate—esophageal cancer	0.00107	0.00268	CcSEcCtD
Hydrocodone—CYP3A4—Biological oxidations—ADH1B—esophageal cancer	0.00106	0.00196	CbGpPWpGaD
Hydrocodone—OPRD1—GPCR downstream signaling—PDE4D—esophageal cancer	0.00105	0.00193	CbGpPWpGaD
Hydrocodone—OPRM1—GPCR ligand binding—SST—esophageal cancer	0.00104	0.00192	CbGpPWpGaD
Hydrocodone—OPRD1—Signaling by GPCR—AKAP13—esophageal cancer	0.00104	0.00192	CbGpPWpGaD
Hydrocodone—CYP2D6—Biological oxidations—PTGS1—esophageal cancer	0.00102	0.00188	CbGpPWpGaD
Hydrocodone—OPRM1—GPCR ligand binding—GHRL—esophageal cancer	0.00101	0.00187	CbGpPWpGaD
Hydrocodone—CYP3A4—Phase 1 - Functionalization of compounds—CYP19A1—esophageal cancer	0.00101	0.00185	CbGpPWpGaD
Hydrocodone—OPRK1—GPCR downstream signaling—AKAP13—esophageal cancer	0.001	0.00185	CbGpPWpGaD
Hydrocodone—OPRD1—GPCR downstream signaling—GNG7—esophageal cancer	0.000995	0.00184	CbGpPWpGaD
Hydrocodone—CYP3A4—Biological oxidations—CYP26A1—esophageal cancer	0.000989	0.00182	CbGpPWpGaD
Hydrocodone—CYP3A4—Metapathway biotransformation—CYP26A1—esophageal cancer	0.000975	0.0018	CbGpPWpGaD
Hydrocodone—OPRD1—Signaling Pathways—ADCYAP1—esophageal cancer	0.000952	0.00176	CbGpPWpGaD
Hydrocodone—OPRD1—Signaling by GPCR—PDE4D—esophageal cancer	0.00095	0.00175	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling Pathways—KMT2D—esophageal cancer	0.000937	0.00173	CbGpPWpGaD
Hydrocodone—CYP3A4—Biological oxidations—GSTO1—esophageal cancer	0.000919	0.0017	CbGpPWpGaD
Hydrocodone—OPRK1—GPCR downstream signaling—PDE4D—esophageal cancer	0.000917	0.00169	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling by GPCR—AKAP13—esophageal cancer	0.000911	0.00168	CbGpPWpGaD
Hydrocodone—CYP3A4—Metapathway biotransformation—GSTO1—esophageal cancer	0.000906	0.00167	CbGpPWpGaD
Hydrocodone—OPRD1—Signaling by GPCR—GNG7—esophageal cancer	0.000904	0.00167	CbGpPWpGaD
Hydrocodone—OPRD1—GPCR downstream signaling—CXCL2—esophageal cancer	0.000877	0.00162	CbGpPWpGaD
Hydrocodone—OPRK1—GPCR downstream signaling—GNG7—esophageal cancer	0.000873	0.00161	CbGpPWpGaD
Hydrocodone—OPRD1—Signaling Pathways—WWOX—esophageal cancer	0.000871	0.00161	CbGpPWpGaD
Hydrocodone—CYP2D6—Biological oxidations—CYP1B1—esophageal cancer	0.000868	0.0016	CbGpPWpGaD
Hydrocodone—CYP2D6—Metapathway biotransformation—CYP1B1—esophageal cancer	0.000857	0.00158	CbGpPWpGaD
Hydrocodone—OPRM1—GPCR downstream signaling—AKAP13—esophageal cancer	0.000848	0.00156	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling Pathways—ADCYAP1—esophageal cancer	0.000835	0.00154	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling by GPCR—PDE4D—esophageal cancer	0.000833	0.00154	CbGpPWpGaD
Hydrocodone—OPRD1—Signaling Pathways—FKBP1A—esophageal cancer	0.000828	0.00153	CbGpPWpGaD
Hydrocodone—CYP2D6—Biological oxidations—CYP19A1—esophageal cancer	0.000817	0.00151	CbGpPWpGaD
Hydrocodone—OPRD1—GPCR downstream signaling—ANXA1—esophageal cancer	0.000815	0.0015	CbGpPWpGaD
Hydrocodone—OPRD1—Signaling Pathways—WIF1—esophageal cancer	0.00081	0.00149	CbGpPWpGaD
Hydrocodone—CYP2D6—Metapathway biotransformation—CYP19A1—esophageal cancer	0.000805	0.00149	CbGpPWpGaD
Hydrocodone—OPRD1—Signaling by GPCR—CXCL2—esophageal cancer	0.000796	0.00147	CbGpPWpGaD
Hydrocodone—OPRD1—GPCR downstream signaling—SST—esophageal cancer	0.000793	0.00146	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling by GPCR—GNG7—esophageal cancer	0.000792	0.00146	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling Pathways—KMT2D—esophageal cancer	0.000792	0.00146	CbGpPWpGaD
Hydrocodone—OPRM1—GPCR downstream signaling—PDE4D—esophageal cancer	0.000775	0.00143	CbGpPWpGaD
Hydrocodone—OPRD1—GPCR downstream signaling—GHRL—esophageal cancer	0.000773	0.00142	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling by GPCR—AKAP13—esophageal cancer	0.00077	0.00142	CbGpPWpGaD
Hydrocodone—OPRK1—GPCR downstream signaling—CXCL2—esophageal cancer	0.000769	0.00142	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling Pathways—WWOX—esophageal cancer	0.000764	0.00141	CbGpPWpGaD
Hydrocodone—CYP3A4—Biological oxidations—ALDH2—esophageal cancer	0.000749	0.00138	CbGpPWpGaD
Hydrocodone—OPRD1—Signaling Pathways—CSNK1A1—esophageal cancer	0.000747	0.00138	CbGpPWpGaD
Hydrocodone—OPRD1—Signaling by GPCR—ANXA1—esophageal cancer	0.00074	0.00137	CbGpPWpGaD
Hydrocodone—OPRM1—GPCR downstream signaling—GNG7—esophageal cancer	0.000737	0.00136	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling Pathways—FKBP1A—esophageal cancer	0.000726	0.00134	CbGpPWpGaD
Hydrocodone—OPRD1—Signaling by GPCR—SST—esophageal cancer	0.00072	0.00133	CbGpPWpGaD
Hydrocodone—OPRK1—GPCR downstream signaling—ANXA1—esophageal cancer	0.000715	0.00132	CbGpPWpGaD
Hydrocodone—CYP3A4—Biological oxidations—GSTT1—esophageal cancer	0.000713	0.00131	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling Pathways—WIF1—esophageal cancer	0.00071	0.00131	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling Pathways—ADCYAP1—esophageal cancer	0.000706	0.0013	CbGpPWpGaD
Hydrocodone—CYP3A4—Biological oxidations—CYP2A6—esophageal cancer	0.000704	0.0013	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling by GPCR—PDE4D—esophageal cancer	0.000704	0.0013	CbGpPWpGaD
Hydrocodone—OPRD1—Signaling by GPCR—GHRL—esophageal cancer	0.000702	0.00129	CbGpPWpGaD
Hydrocodone—OPRD1—Signaling Pathways—PFN1—esophageal cancer	0.000699	0.00129	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling by GPCR—CXCL2—esophageal cancer	0.000698	0.00129	CbGpPWpGaD
Hydrocodone—OPRK1—GPCR downstream signaling—SST—esophageal cancer	0.000695	0.00128	CbGpPWpGaD
Hydrocodone—OPRK1—GPCR downstream signaling—GHRL—esophageal cancer	0.000677	0.00125	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling by GPCR—GNG7—esophageal cancer	0.00067	0.00124	CbGpPWpGaD
Hydrocodone—CYP3A4—Biological oxidations—PTGS1—esophageal cancer	0.000668	0.00123	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling Pathways—CSNK1A1—esophageal cancer	0.000655	0.00121	CbGpPWpGaD
Hydrocodone—OPRM1—GPCR downstream signaling—CXCL2—esophageal cancer	0.00065	0.0012	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling by GPCR—ANXA1—esophageal cancer	0.000649	0.0012	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling Pathways—WWOX—esophageal cancer	0.000645	0.00119	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling by GPCR—SST—esophageal cancer	0.000631	0.00116	CbGpPWpGaD
Hydrocodone—OPRD1—Signaling Pathways—ELMO1—esophageal cancer	0.000628	0.00116	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling by GPCR—GHRL—esophageal cancer	0.000615	0.00113	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling Pathways—FKBP1A—esophageal cancer	0.000614	0.00113	CbGpPWpGaD
Hydrocodone—OPRD1—Signaling Pathways—AKAP13—esophageal cancer	0.000614	0.00113	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling Pathways—PFN1—esophageal cancer	0.000613	0.00113	CbGpPWpGaD
Hydrocodone—OPRM1—GPCR downstream signaling—ANXA1—esophageal cancer	0.000604	0.00111	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling Pathways—WIF1—esophageal cancer	0.0006	0.00111	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling by GPCR—CXCL2—esophageal cancer	0.00059	0.00109	CbGpPWpGaD
Hydrocodone—OPRM1—GPCR downstream signaling—SST—esophageal cancer	0.000588	0.00108	CbGpPWpGaD
Hydrocodone—OPRM1—GPCR downstream signaling—GHRL—esophageal cancer	0.000573	0.00106	CbGpPWpGaD
Hydrocodone—CYP3A4—Biological oxidations—CYP1B1—esophageal cancer	0.000568	0.00105	CbGpPWpGaD
Hydrocodone—OPRD1—Signaling Pathways—HIST1H2BM—esophageal cancer	0.000566	0.00104	CbGpPWpGaD
Hydrocodone—OPRD1—Signaling Pathways—PDE4D—esophageal cancer	0.000561	0.00104	CbGpPWpGaD
Hydrocodone—CYP3A4—Metapathway biotransformation—CYP1B1—esophageal cancer	0.00056	0.00103	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling Pathways—CSNK1A1—esophageal cancer	0.000554	0.00102	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling Pathways—ELMO1—esophageal cancer	0.00055	0.00102	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling by GPCR—ANXA1—esophageal cancer	0.000548	0.00101	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling Pathways—AKAP13—esophageal cancer	0.000538	0.000992	CbGpPWpGaD
Hydrocodone—CYP3A4—Biological oxidations—CYP19A1—esophageal cancer	0.000534	0.000985	CbGpPWpGaD
Hydrocodone—OPRD1—Signaling Pathways—GNG7—esophageal cancer	0.000534	0.000985	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling by GPCR—SST—esophageal cancer	0.000534	0.000984	CbGpPWpGaD
Hydrocodone—CYP3A4—Metapathway biotransformation—CYP19A1—esophageal cancer	0.000527	0.000971	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling by GPCR—GHRL—esophageal cancer	0.00052	0.000959	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling Pathways—PFN1—esophageal cancer	0.000518	0.000955	CbGpPWpGaD
Hydrocodone—OPRD1—Signaling Pathways—XIAP—esophageal cancer	0.0005	0.000923	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling Pathways—HIST1H2BM—esophageal cancer	0.000497	0.000916	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling Pathways—PDE4D—esophageal cancer	0.000492	0.000908	CbGpPWpGaD
Hydrocodone—OPRD1—Signaling Pathways—CTNNA1—esophageal cancer	0.000473	0.000872	CbGpPWpGaD
Hydrocodone—OPRD1—Signaling Pathways—CXCL2—esophageal cancer	0.00047	0.000867	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling Pathways—GNG7—esophageal cancer	0.000468	0.000863	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling Pathways—ELMO1—esophageal cancer	0.000465	0.000858	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling Pathways—AKAP13—esophageal cancer	0.000455	0.000839	CbGpPWpGaD
Hydrocodone—OPRD1—Signaling Pathways—PSME2—esophageal cancer	0.000439	0.00081	CbGpPWpGaD
Hydrocodone—OPRD1—Signaling Pathways—PSME1—esophageal cancer	0.000439	0.00081	CbGpPWpGaD
Hydrocodone—CYP2D6—Metabolism—BLVRB—esophageal cancer	0.000439	0.000809	CbGpPWpGaD
Hydrocodone—CYP2D6—Metabolism—SLC52A3—esophageal cancer	0.000439	0.000809	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling Pathways—XIAP—esophageal cancer	0.000439	0.000809	CbGpPWpGaD
Hydrocodone—OPRD1—Signaling Pathways—ANXA1—esophageal cancer	0.000437	0.000806	CbGpPWpGaD
Hydrocodone—OPRD1—Signaling Pathways—SST—esophageal cancer	0.000425	0.000784	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling Pathways—HIST1H2BM—esophageal cancer	0.00042	0.000774	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling Pathways—PDE4D—esophageal cancer	0.000416	0.000767	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling Pathways—CTNNA1—esophageal cancer	0.000415	0.000765	CbGpPWpGaD
Hydrocodone—OPRD1—Signaling Pathways—GHRL—esophageal cancer	0.000414	0.000764	CbGpPWpGaD
Hydrocodone—OPRD1—Signaling Pathways—NOTCH3—esophageal cancer	0.000414	0.000764	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling Pathways—CXCL2—esophageal cancer	0.000412	0.000761	CbGpPWpGaD
Hydrocodone—OPRD1—Signaling Pathways—FBXW7—esophageal cancer	0.000408	0.000752	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling Pathways—GNG7—esophageal cancer	0.000396	0.00073	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling Pathways—PSME2—esophageal cancer	0.000385	0.00071	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling Pathways—PSME1—esophageal cancer	0.000385	0.00071	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling Pathways—ANXA1—esophageal cancer	0.000383	0.000707	CbGpPWpGaD
Hydrocodone—CYP2D6—Metabolism—CA1—esophageal cancer	0.000373	0.000688	CbGpPWpGaD
Hydrocodone—CYP2D6—Metabolism—SLC10A2—esophageal cancer	0.000373	0.000688	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling Pathways—SST—esophageal cancer	0.000373	0.000688	CbGpPWpGaD
Hydrocodone—OPRD1—Signaling Pathways—NOTCH2—esophageal cancer	0.000372	0.000686	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling Pathways—XIAP—esophageal cancer	0.000371	0.000684	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling Pathways—GHRL—esophageal cancer	0.000363	0.00067	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling Pathways—NOTCH3—esophageal cancer	0.000363	0.00067	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling Pathways—FBXW7—esophageal cancer	0.000358	0.000659	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling Pathways—CTNNA1—esophageal cancer	0.000351	0.000647	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling Pathways—CXCL2—esophageal cancer	0.000349	0.000643	CbGpPWpGaD
Hydrocodone—CYP2D6—Metabolism—CA2—esophageal cancer	0.000341	0.000629	CbGpPWpGaD
Hydrocodone—OPRD1—Signaling Pathways—TGFBR2—esophageal cancer	0.00033	0.000608	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling Pathways—NOTCH2—esophageal cancer	0.000326	0.000601	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling Pathways—PSME2—esophageal cancer	0.000326	0.0006	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling Pathways—PSME1—esophageal cancer	0.000326	0.0006	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling Pathways—ANXA1—esophageal cancer	0.000324	0.000598	CbGpPWpGaD
Hydrocodone—CYP2D6—Metabolism—PLCE1—esophageal cancer	0.000317	0.000585	CbGpPWpGaD
Hydrocodone—CYP2D6—Metabolism—ADH7—esophageal cancer	0.000317	0.000585	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling Pathways—SST—esophageal cancer	0.000315	0.000581	CbGpPWpGaD
Hydrocodone—OPRD1—Signaling Pathways—SMAD4—esophageal cancer	0.000312	0.000576	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling Pathways—GHRL—esophageal cancer	0.000307	0.000567	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling Pathways—NOTCH3—esophageal cancer	0.000307	0.000567	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling Pathways—FBXW7—esophageal cancer	0.000302	0.000557	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling Pathways—TGFBR2—esophageal cancer	0.000289	0.000533	CbGpPWpGaD
Hydrocodone—CYP3A4—Metabolism—BLVRB—esophageal cancer	0.000287	0.000529	CbGpPWpGaD
Hydrocodone—CYP3A4—Metabolism—SLC52A3—esophageal cancer	0.000287	0.000529	CbGpPWpGaD
Hydrocodone—CYP2D6—Metabolism—ADH1B—esophageal cancer	0.000278	0.000513	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling Pathways—NOTCH2—esophageal cancer	0.000275	0.000508	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling Pathways—SMAD4—esophageal cancer	0.000274	0.000505	CbGpPWpGaD
Hydrocodone—CYP2D6—Metabolism—TYMP—esophageal cancer	0.000266	0.00049	CbGpPWpGaD
Hydrocodone—CYP2D6—Metabolism—CYP26A1—esophageal cancer	0.000259	0.000477	CbGpPWpGaD
Hydrocodone—OPRD1—Signaling Pathways—HIF1A—esophageal cancer	0.000255	0.000471	CbGpPWpGaD
Hydrocodone—CYP2D6—Metabolism—ALOX15—esophageal cancer	0.000252	0.000465	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling Pathways—TGFBR2—esophageal cancer	0.000244	0.000451	CbGpPWpGaD
Hydrocodone—OPRD1—Signaling Pathways—KDR—esophageal cancer	0.000244	0.000451	CbGpPWpGaD
Hydrocodone—CYP3A4—Metabolism—SLC10A2—esophageal cancer	0.000244	0.00045	CbGpPWpGaD
Hydrocodone—CYP3A4—Metabolism—CA1—esophageal cancer	0.000244	0.00045	CbGpPWpGaD
Hydrocodone—CYP2D6—Metabolism—TPI1—esophageal cancer	0.00024	0.000443	CbGpPWpGaD
Hydrocodone—CYP2D6—Metabolism—GSTO1—esophageal cancer	0.00024	0.000443	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling Pathways—SMAD4—esophageal cancer	0.000231	0.000427	CbGpPWpGaD
Hydrocodone—CYP2D6—Metabolism—ALDOB—esophageal cancer	0.00023	0.000425	CbGpPWpGaD
Hydrocodone—OPRD1—Signaling Pathways—NOTCH1—esophageal cancer	0.00023	0.000424	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling Pathways—HIF1A—esophageal cancer	0.000224	0.000413	CbGpPWpGaD
Hydrocodone—CYP3A4—Metabolism—CA2—esophageal cancer	0.000223	0.000411	CbGpPWpGaD
Hydrocodone—CYP2D6—Metabolism—GAPDH—esophageal cancer	0.000222	0.000409	CbGpPWpGaD
Hydrocodone—CYP2D6—Metabolism—CRABP1—esophageal cancer	0.00022	0.000406	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling Pathways—KDR—esophageal cancer	0.000214	0.000395	CbGpPWpGaD
Hydrocodone—CYP2D6—Metabolism—GNG7—esophageal cancer	0.000209	0.000386	CbGpPWpGaD
Hydrocodone—OPRD1—Signaling Pathways—CREBBP—esophageal cancer	0.000209	0.000385	CbGpPWpGaD
Hydrocodone—CYP3A4—Metabolism—PLCE1—esophageal cancer	0.000207	0.000383	CbGpPWpGaD
Hydrocodone—CYP3A4—Metabolism—ADH7—esophageal cancer	0.000207	0.000383	CbGpPWpGaD
Hydrocodone—OPRD1—Signaling by GPCR—EGFR—esophageal cancer	0.000205	0.000378	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling Pathways—NOTCH1—esophageal cancer	0.000202	0.000372	CbGpPWpGaD
Hydrocodone—CYP2D6—Metabolism—ALDH2—esophageal cancer	0.000196	0.000361	CbGpPWpGaD
Hydrocodone—OPRD1—GPCR downstream signaling—PIK3CA—esophageal cancer	0.000196	0.000361	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling Pathways—HIF1A—esophageal cancer	0.000189	0.000349	CbGpPWpGaD
Hydrocodone—OPRD1—Signaling Pathways—NOS3—esophageal cancer	0.000187	0.000345	CbGpPWpGaD
Hydrocodone—CYP2D6—Metabolism—GSTT1—esophageal cancer	0.000186	0.000344	CbGpPWpGaD
Hydrocodone—CYP2D6—Metabolism—CYP2A6—esophageal cancer	0.000184	0.00034	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling Pathways—CREBBP—esophageal cancer	0.000183	0.000337	CbGpPWpGaD
Hydrocodone—CYP3A4—Metabolism—ADH1B—esophageal cancer	0.000182	0.000335	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling Pathways—KDR—esophageal cancer	0.000181	0.000334	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling by GPCR—EGFR—esophageal cancer	0.00018	0.000332	CbGpPWpGaD
Hydrocodone—OPRD1—Signaling by GPCR—PIK3CA—esophageal cancer	0.000178	0.000328	CbGpPWpGaD
Hydrocodone—OPRD1—Signaling Pathways—ERBB2—esophageal cancer	0.000175	0.000322	CbGpPWpGaD
Hydrocodone—CYP2D6—Metabolism—ENO1—esophageal cancer	0.000175	0.000322	CbGpPWpGaD
Hydrocodone—CYP2D6—Metabolism—PTGS1—esophageal cancer	0.000175	0.000322	CbGpPWpGaD
Hydrocodone—CYP3A4—Metabolism—TYMP—esophageal cancer	0.000174	0.000321	CbGpPWpGaD
Hydrocodone—CYP2D6—Metabolism—PSME2—esophageal cancer	0.000172	0.000317	CbGpPWpGaD
Hydrocodone—CYP2D6—Metabolism—PSME1—esophageal cancer	0.000172	0.000317	CbGpPWpGaD
Hydrocodone—OPRK1—GPCR downstream signaling—PIK3CA—esophageal cancer	0.000172	0.000317	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling Pathways—NOTCH1—esophageal cancer	0.000171	0.000315	CbGpPWpGaD
Hydrocodone—CYP3A4—Metabolism—CYP26A1—esophageal cancer	0.000169	0.000312	CbGpPWpGaD
Hydrocodone—CYP3A4—Metabolism—ALOX15—esophageal cancer	0.000165	0.000304	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling Pathways—NOS3—esophageal cancer	0.000164	0.000302	CbGpPWpGaD
Hydrocodone—CYP3A4—Metabolism—TPI1—esophageal cancer	0.000157	0.00029	CbGpPWpGaD
Hydrocodone—CYP3A4—Metabolism—GSTO1—esophageal cancer	0.000157	0.00029	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling by GPCR—PIK3CA—esophageal cancer	0.000156	0.000288	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling Pathways—CREBBP—esophageal cancer	0.000155	0.000285	CbGpPWpGaD
Hydrocodone—OPRD1—Signaling Pathways—CCND1—esophageal cancer	0.000154	0.000285	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling Pathways—ERBB2—esophageal cancer	0.000153	0.000283	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling by GPCR—EGFR—esophageal cancer	0.000152	0.00028	CbGpPWpGaD
Hydrocodone—CYP3A4—Metabolism—ALDOB—esophageal cancer	0.000151	0.000278	CbGpPWpGaD
Hydrocodone—OPRD1—Signaling Pathways—CDKN1A—esophageal cancer	0.000149	0.000275	CbGpPWpGaD
Hydrocodone—CYP2D6—Metabolism—CYP1B1—esophageal cancer	0.000149	0.000274	CbGpPWpGaD
Hydrocodone—OPRM1—GPCR downstream signaling—PIK3CA—esophageal cancer	0.000145	0.000268	CbGpPWpGaD
Hydrocodone—CYP3A4—Metabolism—GAPDH—esophageal cancer	0.000145	0.000268	CbGpPWpGaD
Hydrocodone—CYP3A4—Metabolism—CRABP1—esophageal cancer	0.000144	0.000265	CbGpPWpGaD
Hydrocodone—OPRD1—Signaling Pathways—EP300—esophageal cancer	0.000142	0.000262	CbGpPWpGaD
Hydrocodone—CYP2D6—Metabolism—CYP19A1—esophageal cancer	0.00014	0.000258	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling Pathways—NOS3—esophageal cancer	0.000138	0.000255	CbGpPWpGaD
Hydrocodone—CYP3A4—Metabolism—GNG7—esophageal cancer	0.000137	0.000252	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling Pathways—CCND1—esophageal cancer	0.000135	0.00025	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling by GPCR—PIK3CA—esophageal cancer	0.000132	0.000243	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling Pathways—CDKN1A—esophageal cancer	0.000131	0.000242	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling Pathways—ERBB2—esophageal cancer	0.000129	0.000239	CbGpPWpGaD
Hydrocodone—CYP3A4—Metabolism—ALDH2—esophageal cancer	0.000128	0.000236	CbGpPWpGaD
Hydrocodone—CYP2D6—Metabolism—HMOX1—esophageal cancer	0.000127	0.000235	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling Pathways—EP300—esophageal cancer	0.000125	0.00023	CbGpPWpGaD
Hydrocodone—OPRD1—Signaling Pathways—MYC—esophageal cancer	0.000124	0.000228	CbGpPWpGaD
Hydrocodone—CYP2D6—Metabolism—ABCB1—esophageal cancer	0.000122	0.000226	CbGpPWpGaD
Hydrocodone—CYP3A4—Metabolism—GSTT1—esophageal cancer	0.000122	0.000225	CbGpPWpGaD
Hydrocodone—OPRD1—Signaling Pathways—EGFR—esophageal cancer	0.000121	0.000223	CbGpPWpGaD
Hydrocodone—CYP3A4—Metabolism—CYP2A6—esophageal cancer	0.00012	0.000222	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling Pathways—CCND1—esophageal cancer	0.000114	0.000211	CbGpPWpGaD
Hydrocodone—CYP3A4—Metabolism—ENO1—esophageal cancer	0.000114	0.000211	CbGpPWpGaD
Hydrocodone—CYP3A4—Metabolism—PTGS1—esophageal cancer	0.000114	0.000211	CbGpPWpGaD
Hydrocodone—CYP3A4—Metabolism—PSME2—esophageal cancer	0.000113	0.000208	CbGpPWpGaD
Hydrocodone—CYP3A4—Metabolism—PSME1—esophageal cancer	0.000113	0.000208	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling Pathways—CDKN1A—esophageal cancer	0.000111	0.000204	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling Pathways—MYC—esophageal cancer	0.000109	0.0002	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling Pathways—EGFR—esophageal cancer	0.000106	0.000196	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling Pathways—EP300—esophageal cancer	0.000105	0.000194	CbGpPWpGaD
Hydrocodone—OPRD1—Signaling Pathways—PIK3CA—esophageal cancer	0.000105	0.000194	CbGpPWpGaD
Hydrocodone—OPRD1—Signaling Pathways—TP53—esophageal cancer	0.000102	0.000188	CbGpPWpGaD
Hydrocodone—CYP3A4—Metabolism—CYP1B1—esophageal cancer	9.71e-05	0.000179	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling Pathways—PIK3CA—esophageal cancer	9.22e-05	0.00017	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling Pathways—MYC—esophageal cancer	9.18e-05	0.000169	CbGpPWpGaD
Hydrocodone—CYP3A4—Metabolism—CYP19A1—esophageal cancer	9.13e-05	0.000168	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling Pathways—EGFR—esophageal cancer	8.98e-05	0.000166	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling Pathways—TP53—esophageal cancer	8.92e-05	0.000164	CbGpPWpGaD
Hydrocodone—CYP3A4—Metabolism—HMOX1—esophageal cancer	8.33e-05	0.000154	CbGpPWpGaD
Hydrocodone—CYP2D6—Metabolism—CREBBP—esophageal cancer	8.17e-05	0.000151	CbGpPWpGaD
Hydrocodone—CYP3A4—Metabolism—ABCB1—esophageal cancer	8e-05	0.000147	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling Pathways—PIK3CA—esophageal cancer	7.79e-05	0.000144	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling Pathways—TP53—esophageal cancer	7.54e-05	0.000139	CbGpPWpGaD
Hydrocodone—CYP2D6—Metabolism—NOS3—esophageal cancer	7.32e-05	0.000135	CbGpPWpGaD
Hydrocodone—CYP2D6—Metabolism—PTGS2—esophageal cancer	6.69e-05	0.000123	CbGpPWpGaD
Hydrocodone—CYP2D6—Metabolism—EP300—esophageal cancer	5.57e-05	0.000103	CbGpPWpGaD
Hydrocodone—CYP3A4—Metabolism—CREBBP—esophageal cancer	5.34e-05	9.86e-05	CbGpPWpGaD
Hydrocodone—CYP3A4—Metabolism—NOS3—esophageal cancer	4.78e-05	8.83e-05	CbGpPWpGaD
Hydrocodone—CYP3A4—Metabolism—PTGS2—esophageal cancer	4.38e-05	8.07e-05	CbGpPWpGaD
Hydrocodone—CYP2D6—Metabolism—PIK3CA—esophageal cancer	4.12e-05	7.6e-05	CbGpPWpGaD
Hydrocodone—CYP3A4—Metabolism—EP300—esophageal cancer	3.64e-05	6.71e-05	CbGpPWpGaD
Hydrocodone—CYP3A4—Metabolism—PIK3CA—esophageal cancer	2.69e-05	4.97e-05	CbGpPWpGaD
